🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-27
Trial ID
NCT03392961
Treatments Being Tested
Food allergy is a serious public health concern that causes potentially-lif...
Status
Completed
Location
University of California Los Angeles (UCLA)
Start Date
2020-02-05
Trial ID
NCT03679676
Treatments Being Tested
This first-in-human clinical trial with a randomized, double-blind, placebo...
Status
Completed
Location
Parexel Los Angeles Early Phase Clinical Unit
Start Date
2023-12-21
Trial ID
NCT06225115
This study is being done for the following reasons: To determine the safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-03
Trial ID
NCT01807026
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
Anapharm
Start Date
2008-07
Trial ID
NCT00734240
This is a phase 1, multi-center, double-blind, placebo-controlled, multiple...
Status
Completed
Location
University of California San Diego
Start Date
2021-02-16
Trial ID
NCT04539041
Treatments Being Tested
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262
The purpose of this study is to evaluate the safety, tolerability, and drug...
Status
Completed
Location
ICON Plc (PRA Health Sciences) - Netherlands
Start Date
2020-09-17
Trial ID
NCT04550195
Treatments Being Tested